CancerTools.org, a unique non-profit cancer research tool supplier and part of Cancer Research UK, has chosen Discovery Park as the home of their first UK-based laboratory, growing their team at the Sandwich Science and Tech campus.
Since establishing its presence at Discovery Park in 2023, CancerTools.org has expanded its operations, enhancing its capacity to provide high-quality cancer research tools to the global scientific community. Many of these tools are contributed by leading academic laboratories and researchers, reflecting the organisation’s collaborative approach. The organisation looks forward to driving its mission to empower scientists and accelerate cancer discoveries worldwide.
Mayer Schreiber, CEO of Discovery Park, said:
“I’m delighted to see the remarkable growth of the CancerTools.org team since opening their first UK laboratory at Discovery Park. Their incredible biorepository network is solving a real problem in cancer research, helping to accelerate discoveries by sharing knowledge around the world. CancerTools.org is an asset to the ecosystem at Discovery Park, creating valuable opportunities for collaboration and knowledge exchange between tenants working in oncology.”
CancerTools.org continues to focus on its mission to accelerate cancer research by enabling global access to innovative tools and reagents. The organisation works collaboratively with scientists, academic spinouts, emerging biotech, and pharmaceutical teams alike – strengthening innovation and sustainable science across the cancer research landscape.
For more information, visit cancertools.org.
About Discovery Park
Discovery Park is one of the UK’s leading science and innovation campuses, providing a dynamic base for life science companies ranging from early-stage start-ups to global corporations. Located in Kent, with excellent connectivity to London and Europe, Discovery Park offers an ideal environment for businesses to start, scale and succeed.
With more than 180 companies on site, including Pfizer, Asymchem, Viatris, Concept Life Sciences, Resolian, Psyros Diagnostics, York Bio, and VisusNano, Discovery Park is home to a thriving ecosystem of innovators. The 220-acre site offers cutting-edge laboratories, flexible office and manufacturing space, and a highly supportive infrastructure tailored to the needs of science and technology businesses.
Recognised as a Life Science Opportunity Zone, Discovery Park benefits from a robust utilities infrastructure, 100% renewable electricity, and a strong pipeline of local STEM talent, underpinned by partnerships with leading academic institutions. With its strategic location, vibrant community, and access to finance through its own fund, Discovery Park Ventures, the campus plays a central role in Kent’s flourishing science and technology cluster and is an extension of the UK’s prestigious Golden Triangle.
For further information, please contact: Kirsty Budden, Head of Marketing
E: [email protected], T: +44 (0) 7730 618514
You can find more insights and news on OncoDaily.